Oct 02, 2024, 8:00 AM ETAbbVie Inc. (ABBV) Per FDA requirement for this indication, Allergan Aesthetics is providing a product training program for providers, which includes facial anatomy and ...
HOUSTON, TX--(Marketwired - Feb 19, 2015) - Dermal fillers and injectables can be excellent options for many patients who are interested in facial rejuvenation but do not yet require and/or desire ...
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
Dermatologists and plastic surgeons have a new, nonsurgical weapon to add to their anti-aging arsenal. Juvéderm Voluma XC was approved by the U.S. Food and Drug Administration in December as the first ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE:AGN) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLUMA™ XC, the ...
Add Yahoo as a preferred source to see more of our stories on Google. In the great big world of facial fillers, two of the most popular—Restylanë and Juvéderm—often get conflated. Patients often ask, ...
Please provide your email address to receive an email when new articles are posted on . Juvéderm Voluma for facial revolumization produced results lasting up to a year in patients with little risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results